| New-onset IgG autoantibodies in hospitalized patients with COVID-19 SE Chang, A Feng, W Meng, SA Apostolidis, E Mack, M Artandi, L Barman, ... Nature communications 12 (1), 5417, 2021 | 452 | 2021 |
| Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine C Li, A Lee, L Grigoryan, PS Arunachalam, MKD Scott, M Trisal, ... Nature immunology 23 (4), 543-555, 2022 | 347 | 2022 |
| Targeted glycan degradation potentiates the anticancer immune response in vivo MA Gray, MA Stanczak, NR Mantuano, H Xiao, JFA Pijnenborg, ... Nature chemical biology 16 (12), 1376-1384, 2020 | 273 | 2020 |
| Efficient evolution of human antibodies from general protein language models BL Hie, VR Shanker, D Xu, TUJ Bruun, PA Weidenbacher, S Tang, W Wu, ... Nature Biotechnology 42 (2), 275-283, 2024 | 260 | 2024 |
| A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice AE Powell, K Zhang, M Sanyal, S Tang, PA Weidenbacher, S Li, TD Pham, ... ACS central science 7 (1), 183-199, 2021 | 172 | 2021 |
| Chemical modification-assisted bisulfite sequencing (CAB-Seq) for 5-carboxylcytosine detection in DNA X Lu, CX Song, K Szulwach, Z Wang, P Weidenbacher, P Jin, C He Journal of the American Chemical Society 135 (25), 9315-9317, 2013 | 136 | 2013 |
| A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates PAB Weidenbacher, M Sanyal, N Friedland, S Tang, PS Arunachalam, ... Nature Communications 14 (1), 2149, 2023 | 57 | 2023 |
| Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope PA Weidenbacher, PS Kim Proceedings of the National Academy of Sciences 116 (20), 9947-9952, 2019 | 47 | 2019 |
| Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors PAB Weidenbacher, E Waltari, I de los Rios Kobara, BN Bell, MK Morris, ... Nature Chemical Biology 18 (11), 1270-1276, 2022 | 17 | 2022 |
| Bringing immunofocusing into focus S Musunuri, PAB Weidenbacher, PS Kim npj Vaccines 9 (1), 11, 2024 | 12 | 2024 |
| Targeted desialylation overcomes glyco-immune checkpoints and potentiates the anticancer immune response in vivo M Gray, MA Stanczak, H Xiao, JFA Pijnenborg, NR Mantuano, SA Malaker, ... | 11 | 2019 |
| Vaccine design via antigen reorientation D Xu, JJ Carter, C Li, A Utz, PAB Weidenbacher, S Tang, M Sanyal, ... Nature Chemical Biology, 1-10, 2024 | 10 | 2024 |
| New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 12: 5417 SE Chang, A Feng, W Meng, SA Apostolidis, E Mack, M Artandi, L Barman, ... | 8 | 2021 |
| Simplified purification of glycoprotein-modified ferritin nanoparticles for vaccine development P Weidenbacher, S Musunuri, AE Powell, S Tang, J Do, M Sanyal, PS Kim Biochemistry 62 (2), 292-299, 2022 | 6 | 2022 |
| Chemically modified bacterial sacculi as a vaccine microparticle scaffold PAB Weidenbacher, FP Rodriguez-Rivera, M Sanyal, JA Visser, J Do, ... ACS Chemical Biology 17 (5), 1184-1196, 2022 | 5 | 2022 |
| Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines OS Kumru, M Sanyal, N Friedland, JM Hickey, R Joshi, P Weidenbacher, ... Vaccine 41 (44), 6502-6513, 2023 | 3 | 2023 |
| Designing epitope-focused vaccines via antigen reorientation D Xu, C Li, A Utz, PAB Weidenbacher, S Tang, M Sanyal, B Pulendran, ... bioRxiv, 2022 | 2 | 2022 |
| Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into broad-spectrum inhibitors through receptor blockade PAB Weidenbacher, E Waltari, I de los Rios Kobara, BN Bell, JE Pak, ... BioRxiv, 2022.01. 24.477625, 2022 | 2 | 2022 |
| A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses AE Powell, H Caruso, S Park, JL Chen, J O’Rear, BJ Ferrer, A Walker, ... bioRxiv, 2024.07. 01.601243, 2024 | 1 | 2024 |
| Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates PAB Weidenbacher, M Sanyal, N Friedland, S Tang, PS Arunachalam, ... nature communications 14, 6211, 2023 | 1 | 2023 |
